Pharmacodynamic Bioequivalence Study of Albuterol Sulfate Inhalation Aerosol, 0.09 mg Albuterol Base/ Inhalation
Condition: Bronchial Asthma Interventions: Other: Methacholine Chloride; Drug: Albuterol Sulfate HFA 0.09 mg (Reference); Drug: Albuterol Sulfate HFA 0.18 mg (Reference); Drug: Albuterol Sulfate HFA 0.09 mg (Test); Drug: Albuterol Sulfate HFA 0.18 mg (Test); Drug: Placebo Sponsor: Aurobindo Pharma Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 23, 2022 Category: Research Source Type: clinical trials
Levalbuterol Compared to Albuterol Regarding Cardiac Side Effects and Potassium Lowering Effects.
Condition: Hyperkalemia Interventions: Drug: Levalbuterol; Drug: Albuterol Sponsor: University of Aleppo Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 30, 2021 Category: Research Source Type: clinical trials